Vivos Therapeutics, Inc. (VVOS) Financials

VVOS Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 10.3 million 10.3 million
2023-06-30 13.7 million 11.6 million
2023-03-31 17.1 million 10.1 million
2022-12-31 13.7 million 8.9 million

VVOS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -3.0 million 189000
2023-06-30 -3.1 million 459000
2023-03-31 -3.8 million 306000
2022-12-31 -3.2 million 775000

VVOS Net Income

No data available :(

VVOS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 988000 - 2.1 million
2023-06-30 3.9 million - 2.2 million
2023-03-31 7.0 million - 2.3 million
2022-12-31 3.5 million - 2.4 million

VVOS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 1.2 million
2023-06-30 1.2 million
2023-03-31 990562
2022-12-31 1.1 million

VVOS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 154000 100000 4.6 million 641000
2023-06-30 245000 100000 5.9 million 590000
2023-03-31 239000 - 6.5 million 630000
2022-12-31 200000 - 6.9 million 1.4 million

VVOS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 3.3 million 1.4 million
2023-06-30 3.4 million 1.3 million
2023-03-31 3.9 million 1.5 million
2022-12-31 4.0 million 1.6 million

VVOS

Price: $2.60

52 week price:
2.40
48.79

Earnings Per Share: -11.14 USD

P/E Ratio: -0.38

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Volume: 77800

Market Capitalization: 7.9 million

Links: